Ahmed M E Elkhalifa

Dr. Ahmed M E Elkhalifa

Saudi Electronic University, Riyadh, Ar Riyāḑ, Saudi Arabia
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Heliyon
Verified
Journal Article
Open access
STShahana Riyaz Tramboo
Shahana Riyaz Tramboo
AEAhmed M E Elkhalifa
Ahmed M E Elkhalifa
SQSyed Quibtiya
Syed Quibtiya
SASofi Imtiyaz Ali
Sofi Imtiyaz Ali
NSNaveed Nazir Shah
Naveed Nazir Shah
SNShowkat Ul Nabi
Showkat Ul Nabi
Cytokine storm (CS) refers to the spontaneous dysregulated and hyper-activated inflammatory reaction occurring in various clinical conditions, ranging from microbial infection to end-stage organ failure. Recently the novel coronavirus involved in COVID-19 (Coronavirus disease-19) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has been associated with the pathological phenomenon of CS in critically ill patients. Furthermore, critically ill patients suffering from CS are likely to have a grave prognosis and a higher case fatality rate. Pathologically CS is manifested as hyper-immune activation and is clinically manifested as multiple organ failure. An in-depth understanding of the etiology of CS will enable the discovery of not just disease risk factors of CS but also therapeutic approaches to modulate the immune response and improve outcomes in patients with respiratory diseases having CS in the pathogenic pathway. Owing to the grave consequences of CS in various diseases, this phenomenon has attracted the attention of researchers and clinicians throughout the globe. So in the present manuscript, we have attempted to discuss CS and its ramifications in COVID-19 and other respiratory diseases, as well as prospective treatment approaches and biomarkers of the cytokine storm. Furthermore, we have attempted to provide in-depth insight into CS from both a prophylactic and therapeutic point of view. In addition, we have included recent findings of CS in respiratory diseases reported from different parts of the world, which are based on expert opinion, clinical case-control research, experimental research, and a case-controlled cohort approach.

31 May 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
AEAhmed M E Elkhalifa
Ahmed M E Elkhalifa
RARashad Abdul-Ghani
Rashad Abdul-Ghani
ATAbdelhakam G. Tamomh
Abdelhakam G. Tamomh
NENur Eldin Eltaher
Nur Eldin Eltaher
NANada Y. Ali
Nada Y. Ali
OAOmnia A. M. Alhasan
Omnia A. M. Alhasan
Background: Hematological abnormalities are common features in falciparum malaria but vary among different populations across countries. Therefore, we compared hematological indices and abnormalities between Plasmodium falciparum-infected patients and malaria-negative subjects in Kosti city of the White Nile State, Sudan. Methods: A comparative, cross-sectional study was conducted at the Clinical Laboratory Unit of Kosti Teaching Hospital from June to December 2018. A total of 392 participants (192 P. falciparum-infected patients and 200 malaria-negative subjects) were recruited in the study. Hematological indices of hemoglobin (Hb), red blood cells (RBCs), white blood cells (WBCs) and platelets were measured, and their median values were statistically compared. Results: The majority of P. falciparum-infected patients (67.6%) showed a low-level parasitemia. The median values of Hb concentration, RBC count, mean corpuscular volume (MCV), mean corpuscular Hb (MCH) and mean corpuscular Hb concentration (MCHC) were significantly lower in P. falciparum-infected patients, while the median red cell distribution width (RDW) was significantly higher in the patients compared to malaria-negative subjects. Anemia, low MCV, low MCH, low MCHC and high RDW were significantly associated with falciparum malaria, but parasitemia level was not significantly associated with anemia severity. The median total WBC count was non-significantly higher in P. falciparum-infected patients, with neutropenia being significantly associated with falciparum malaria. The median platelet count was significantly lower in P. falciparum-infected patients, with thrombocytopenia being significantly associated with falciparum malaria. Conclusions: Falciparum malaria among patients in Kosti city of the White Nile State, Sudan is predominantly of low-level parasitemia. It is significantly associated with anemia, low MCV, low MCH, low MCHC, high RDW, thrombocytopenia and neutropenia. However, parasitemia level is not a significant predictor of anemia severity. On the other hand, leucopenia is not useful to predict falciparum malaria. Further large-scale studies in community and healthcare settings and inclusion of patients with complicated or severe malaria and those with high parasite densities are recommended.

8 January 2024 in Life
Verified
Journal Article
Open access
PDF file
AEAhmed M E Elkhalifa
Ahmed M E Elkhalifa
MNMehak Nazar
Mehak Nazar
SASofi Imtiyaz Ali
Sofi Imtiyaz Ali
IKIbraq Khursheed
Ibraq Khursheed
STSyed Taifa
Syed Taifa
SNShowkat Ul Nabi
Showkat Ul Nabi
Diabetes mellitus (DM) is characterized by an absolute decline in insulin secretion and peripheral resistance and is the most prevalent metabolic and endocrine disorder. However, the pathogenesis of DM also includes adipocyte insulin resistance, increased glucagon secretion, increased renal glomerular glucose absorption, and neurotransmitter dysfunction. Although there is a wide spectrum of therapeutics available for glycemic control, owing to the identification of various pathogenic determinants of DM, management of DM remains challenging and complex. Current therapeutic interventions against DM focus mostly on glycemic control without considering the other pathological determinants that eventually lead to treatment failure and the progression of DM. Furthermore, long-term use of these conventionally available anti-diabetic drugs leads to various side effects, henceforth development of novel drugs against DM remains an unending search strategy for researchers. Various studies conducted in various parts of the world have proposed that these novel therapeutic interventions target multiple and alternate pathogenic hotspots involved in DM. The current review article discusses novel therapeutic options that hold particular promise to support their safety and discuss the side effects resulting from their use so that these novel candidate drugs can be effectively fabricated into potential drugs for the treatment of DM.

5 February 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
AEAhmed M E Elkhalifa
Ahmed M E Elkhalifa
SNShowkat Ul Nabi
Showkat Ul Nabi
OSOvais Shabir Shah
Ovais Shabir Shah
SBShowkeen Muzamil Bashir
Showkeen Muzamil Bashir
UMUmar Muzaffer
Umar Muzaffer
AAAbdulaziz H. A. Alharbi
Abdulaziz H. A. Alharbi
As per a recent study conducted by the WHO, 15.4% of all cancers are caused by infectious agents of various categories, and more than 10% of them are attributed to viruses. The emergence of COVID-19 has once again diverted the scientific community’s attention toward viral diseases. Some researchers have postulated that SARS-CoV-2 will add its name to the growing list of oncogenic viruses in the long run. However, owing to the complexities in carcinogenesis of viral origin, researchers across the world are struggling to identify the common thread that runs across different oncogenic viruses. Classical pathways of viral oncogenesis have identified oncogenic mediators in oncogenic viruses, but these mediators have been reported to act on diverse cellular and multiple omics pathways. In addition to viral mediators of carcinogenesis, researchers have identified various host factors responsible for viral carcinogenesis. Henceforth owing to viral and host complexities in viral carcinogenesis, a singular mechanistic pathway remains yet to be established; hence there is an urgent need to integrate concepts from system biology, cancer microenvironment, evolutionary perspective, and thermodynamics to understand the role of viruses as drivers of cancer. In the present manuscript, we provide a holistic view of the pathogenic pathways involved in viral oncogenesis with special emphasis on alteration in the tumor microenvironment, genomic alteration, biological entropy, evolutionary selection, and host determinants involved in the pathogenesis of viral tumor genesis. These concepts can provide important insight into viral cancers, which can have an important implication for developing novel, effective, and personalized therapeutic options for treating viral cancers.

28 September 2022 in Bioinorganic Chemistry and Applications
Verified
Journal Article
Open access
PDF file
AEAbozer Elderdery
Abozer Elderdery
BABadr Alzahrani
Badr Alzahrani
AAAbdulrahim A. Alabdulsalam
Abdulrahim A. Alabdulsalam
SHSiddiqa M. A. Hamza
Siddiqa M. A. Hamza
AEAhmed M E Elkhalifa
Ahmed M E Elkhalifa
PMPooi Ling Mok
Pooi Ling Mok
Currently, new advancements in the area of nanotechnology opened up new prospects in the field of medicine that could provide us with a solution for numerous medical complications. Although a several varieties of nanoparticles is being explored to be used as nanomedicines, cerium oxide nanoparticles (CeO2 NPs) are the most attractive due to their biocompatibility and their switchable oxidation state (+3 and +4) or in other words the ability to act as prooxidant and antioxidant depending on the pH condition. Green synthesis of nanoparticles is preferred to make it more economical, eco‐friendly, and less toxic. The aim of our study here is to formulate the CeO2 NPs (CeO2 NPs) using Morinda citrifolia (Noni) leaf extract and study its optical, structural, antibacterial, and anticancer abilities. Their optical and structural characterization was accomplished by employing X‐ray diffractography (XRD), TEM, EDAX, FTIR, UV‐vis, and photoluminescence assays. Our CeO2 NPs expressed strong antibacterial effects against Gram‐positive S. aureus and S. pneumonia in addition to Gram‐negative E. coli and K. pneumonia when compared with amoxicillin. The anticancer properties of the green synthesized CeO2 NPs against human acute lymphoblastic leukemia (ALL) MOLT‐4 cells were further explored by the meticulous study of their ability to diminish cancer cell viability (cytotoxicity), accelerate apoptosis, escalate intracellular reactive oxygen species (ROS) accumulation, decline the mitochondria membrane potential (MMP) level, modify the cell adhesion, and shoot up the activation of proapoptotic markers, caspase−3, −8, and −9, in the tumor cells. Altogether, the outcomes demonstrated that our green synthesized CeO2 NPs are an excellent candidate for alternative cancer therapy.

31 January 2022 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
AEAbozer Elderdery
Abozer Elderdery
AEAhmed M E Elkhalifa
Ahmed M E Elkhalifa
AAAbdullah Alsrhani
Abdullah Alsrhani
KZKhalid I. Zawbaee
Khalid I. Zawbaee
SASaad M. Alsurayea
Saad M. Alsurayea
JMjeremy mills
jeremy mills
This study is aimed at evaluating the association between Coronavirus disease 19 (COVID‐19) and the primary complete blood count (CBC) parameters in confirmed positive patients. In a retrospective cross‐sectional study, 384 files of patients with confirmed COVID‐19 diagnosis hospitalized at King Saud Medical City, Riyadh, were chosen randomly as a study group for hematological parameters, with another 384 non‐COVID‐19 files of patients without history of any disease which could influence the hematological profile were selected as a control group. The gender, age, and nationality of the control group were matched with those of the study group. Anemia and thrombocytopenia prevalence was significantly higher in COVID‐19 positive patients compared with negative. However, the positive cases were 3.4 times more likely to be anemic and approximately 5.3 times as likely to be thrombocytopenic, while the prevalence of leukopenia showed no statistical significance between the two groups. However, the Mean Cell Volume (MCV), Total White Blood Cell (WBC) count, lymphocyte count, and basophil count median values showed a nonsignificant difference between the two groups. Anemia and thrombocytopenia may be highly developed in severe positive cases, and therefore, further studies are recommended to validate these findings.